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Background: We examined whether diabetes-related psychosocial factors differ between 
  African American and white patients with type 2 diabetes. We also tested whether racial 
  differences in glycemic control are independent of such factors.
Methods: Baseline glycosylated hemoglobin (HbA1c) and survey measures from 79 African 
American and 203 white adult participants in a diabetes self-management clinical trial were 
analyzed.
Results: Several psychosocial characteristics varied by race. Perceived interference of 
  diabetes with daily life, perceived diabetes severity, and diabetes-related emotional distress 
were higher for African Americans than for whites, as were access to illness-management 
resources and social support. Mean HbA1c levels were higher among African Americans than 
whites (8.14 vs 7.40, beta = 0.17). This difference persisted after adjusting for demographic, 
clinical, and   diabetes-related psychosocial characteristics that differed by race (beta = 0.18). 
Less access to illness-management resources (beta = –0.25) and greater perceived severity of 
diabetes (beta = 0.21) also predicted higher HbA1c.
Discussion: Although racial differences in diabetes-related psychosocial factors were observed, 
African Americans continued to have poorer glycemic control than whites even after such differ-
ences were taken into account. Interventions that target psychosocial factors related to diabetes 
management, particularly illness-management resources, may be a promising way to improve 
glycemic control for all patients.
Keywords: diabetes mellitus, type 2, minority health, health status disparities, psychosocial 
factors, disease management
An estimated 17.9 million people in the United States had a diagnosis of diabetes in 
2007, with direct and indirect costs associated with diabetes totalling $174 billion.1 
The burden of this prevalent and costly disease falls disproportionately on African 
  Americans, with recent estimates indicating that 14.7% of non-Hispanic African 
  American adults have diabetes, compared with 9.8% of non-Hispanic whites.1 Not only 
is diabetes more prevalent among African Americans,2–6 but among those diagnosed 
with diabetes, African Americans are less likely than whites to achieve adequate 
control of blood glucose levels7–19 and are more likely than whites to suffer diabetes-
related complications such as nephropathy, end-stage renal disease, retinopathy, 
  lower-extremity amputations, and mortality.15,20–30
Given that maintaining near-normal levels of blood glucose can greatly reduce 
the risk of experiencing diabetic complications,31 it is important to understand why 
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diabetes management, and determining whether these factors 
operate the same for African American and white patients, 
would allow the strategic development and implementation of 
interventions designed to reduce disparities between groups. 
However, few factors underlying the racial gap in glycemic 
control have been identified. Several studies have shown that 
racial differences in glycemic control persist after controlling 
for demographic, clinical, and behavioral factors such as 
age, sex, body mass index, education, socioeconomic status, 
physical comorbidities, depression, diabetes treatment regi-
men, access to health care, adherence to diabetes medications, 
and physical activity levels.7,8,11–13,16,32–34 Racial differences in 
glycemic control are also not fully explained by differences 
in processes of care, as rates of obtaining standard tests and 
screenings for comprehensive diabetes management are often 
equivalent or higher for African Americans compared with 
whites.10,15,35–41
Achieving and maintaining adequate glycemic control 
can require the adoption of multiple behaviors that involve 
diet, exercise, and appropriate intake of insulin and/or oral 
hypoglycemic medications, resulting in a complicated 
regimen that poses significant challenges to patients. Social 
cognitive theory (SCT) maintains that whether patients 
adopt desired behaviors is influenced by the interaction of 
intrapersonal factors (eg, belief in one’s ability to adopt the 
behavior or the expected utility of adopting the behavior) and 
environmental factors (eg, social support for the behavior 
or lack of external barriers).42 The basic tenets of SCT are 
supported by a large body of evidence showing that factors 
such as self efficacy in disease management and social 
support are associated with increased adherence to recom-
mended diabetes self-management behaviors and improved 
glycemic control.43–48 Much of the early work applying 
SCT to diabetes management, however, did not examine 
whether there were racial differences in intrapersonal and 
environmental factors related to diabetes management (here-
tofore referred to as diabetes-related psychosocial factors) 
or whether such factors had different effects on diabetes 
outcomes for these groups.
More recent work has begun to focus on whether the 
tenets of SCT generalize to diabetes management among 
African American patients, but studies have yielded mixed 
results.49–54 The influence of social support and self efficacy 
on various self-care domains has been inconsistent in 
African American samples, with some studies finding no 
relationships54 and others finding relationships with some, 
but not all, self-care domains (eg, glucose monitoring and 
exercise, but not medication adherence).49,50,53 There is also 
evidence that diabetes-related emotional distress, which may 
interfere with diabetes management behaviors, is not related 
to glucose control among African Americans.55 However, 
few studies have directly examined whether diabetes-related 
psychosocial factors such as these differ between African 
Americans and whites or whether racial differences in 
glycemic control persist after taking into account racial dif-
ferences in diabetes-related psychosocial factors.
We attempted to address this gap in the literature by 
exploring whether racial differences exist for several psy-
chosocial factors found in past research to be associated 
with improved diabetes self-care and/or glycemic control. 
These included factors pertaining to self-care and quality of 
life (eg, self-efficacy in diabetes self-management, diabetes-
related social support, perceived severity of one’s disease), 
access to resources that support disease management, and 
emotional distress related to diabetes. We further examined 
whether racial differences in glycemic control remained after 
taking into account race differences in these factors. We exam-
ined these issues using baseline data from African American 
and white patients enrolled in a clinical trial of a behavioral 
intervention to improve diabetes self-management.
Methods
Patient population
Data for this analysis consisted of baseline measures col-
lected from patients enrolled in the ENHANCE study, a 
  single-center, randomized controlled trial of a behavioral 
intervention designed to foster adherence of individuals 
with type 2 diabetes to their self-management regimen. 
  Participants were recruited from Pittsburgh,   Pennsylvania and 
the   surrounding area. Adults with a self-reported   diagnosis 
of type 2 diabetes were eligible for enrollment in the trial. 
Exclusion criteria included (1) history of hypoglycemic 
coma/seizure within the last 12 months, (2) hypoglycemia 
requiring 3rd party assistance within the last 3 months, 
(3) unwillingness to do capillary blood testing, (4)   history 
consistent with type 1 diabetes, (5)   unwillingness or inability 
to participate in scheduled group classes, (6) renal dialysis or 
expectation of dialysis within the next 6 months, (7)   history 
of dementia, alcohol, or substance abuse, (8) plans to move 
outside of the study region within the next 8 months, and 
(9) participation in another clinical study. Eligible   participants 
were scheduled for a baseline   fasting laboratory measurement 
visit and   completed a baseline survey (described below). Data 
collected from participants during their baseline visit were 
used in the current analyses. Complete details regarding the 
intervention and study design are available elsewhere.56Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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Measurements
Two weeks prior to their baseline assessment visit,   eligible 
participants were sent a packet of questionnaires that 
  contained measures of demographic, clinical, and diabetes-
related psychosocial factors used in the current analyses. 
Demographic and clinical factors included self-reported 
race and ethnicity, gender, years of formal education, annual 
household income, employment status, health insurance 
status, and diabetes medication regimen (coded as ‘includes 
insulin vs does not include insulin’ for analyses). Total caloric 
expenditure through physical activity was also assessed 
using the Community Health Activities Model Program for 
Seniors questionnaire (CHAMPS).57 Physical and mental 
comorbidities were assessed using the Rigler comorbidity 
checklist58 and Beck Depression Inventory-II,59 respectively. 
Descriptions of the diabetes-related psychosocial factors and 
how they were measured are provided in Table 1.
During the baseline assessment visit, signed informed 
consent was obtained, after which questionnaires were 
  collected and reviewed for completeness. Staff also obtained 
measures of height and weight at that time, which were used 
to calculate body mass index (BMI). Glycemic   control was 
determined by serum hemoglobin A1c (HbA1c) levels obtained 
via venipuncture. At the completion of the baseline visit, 
participants were given a $20 gift certificate to a local grocery 
store and parking vouchers or bus passes were   provided as 
needed. The study was approved by the Institutional Review 
Board of the University of Pittsburgh.
statistical analysis
We first determined whether there were significant (P , 0.05) 
racial differences in each demographic, clinical, and 
diabetes-related psychosocial factor by examining bivariate 
associations between race and each variable. Continuous vari-
ables were summarized using means and standard deviations; 
categorical variables were summarized by   frequencies and 
percentages. Bivariate associations between race and each 
variable were assessed using Student’s t-test or its nonpara-
Table 1 summary of psychosocial measures
Variable Description Measurement  
tool
# of items Possible  
range
Cronbach’s   
alpha
Access to illness- 
management resources
support (eg, informational or emotional)  
for the management of chronic illness  
available from one’s physician/health care  
team, family/friends, personal actions, 
neighborhood, community, media/policy, 
community organizations, and workplace
cirs65 64 1–5 0.91
interference of  
diabetes with daily life
interference caused by diabetes to daily  
activities, work, and social/recreational  
activities
MDQ subscale45 9 0–6 0.93
Perceived severity  
of diabetes
extent to which diabetes is a severe  
health problem and causes concern/worry
MDQ subscale45 3 0–6 0.87
Perceived diabetes- 
related social support
Social support received from significant  
others, family, friends, and health  
professionals
MDQ subscale45 4 0–6 0.74
Positive reinforcing  
behaviors
Reinforcement received from significant  
others for engaging in desirable  
self-management behaviors
MDQ subscale45 8 0–6 0.91
Misguided support  
behaviors
Nonsupportive behaviors by significant  
others to encourage self-management  
behaviors (eg, nagging)
MDQ subscale45 4 0–6 0.82
Self efficacy in diabetes  
self management
Confidence in ability to perform  
desirable self-management behaviors
MDQ subscale45 7 0–100 0.91
Outcome expectancies  
for self-care behaviors
Perceptions of the effects of desirable  
self-management behaviors on metabolic  
control and prevention of complications
MDQ subscale45 6 0–100 0.88
Diabetes-related  
emotional distress
emotional responses to issues unique  
to living with diabetes
PAiD66 20 0–100 0.94
Abbreviations: cirs, chronic illness resources survey; MDQ, Multidimensional Diabetes Questionnaire; PAiD, Problem Areas in Diabetes scale.Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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metric equivalent (eg, Wilcoxon rank sum test) for continuous 
variables and by the χ2 statistic for   categorical variables.
Next, we used linear regression to examine whether 
race was associated with HbA1c level prior to adjusting for 
any additional variables. We then examined multiple linear 
  regression models to determine whether race was   associated 
with HbA1c level after adjustment for variables that were found 
to differ by race in the bivariate analyses at a P value of at 
least marginal significance (P , 0.10). The first   multivariable 
model included race and patient demographic and clinical 
factors that differed by race. The second multivariable model 
consisted of the first model plus the psychosocial factors that 
differed by race. Finally, we examined an additional set of 
models that tested the interaction effects of race and each 
variable on HbA1c to determine whether the effects of these 
variables on glycemic control differed for African American 
and white patients. All analyses were performed using SAS 
software (version 9.2; SAS Institute, Cary, NC, USA).
Results
racial differences in demographic  
and clinical characteristics
African Americans and whites differed on several demo-
graphic and clinical characteristics (Table 2). Compared 
with whites, African Americans were significantly younger 
(mean age = 51.1 vs 57.3), had fewer years of education 
(13.4 vs 15.0), expended more calories during physical 
activity (4228.3 vs 3354.8), and had fewer comorbid 
conditions (3.3 vs 3.9). There was a marginal trend for 
African Americans to score higher than whites on the Beck 
Depression Index (0.6 vs 0.5). African Americans were also 
more likely than whites to be female (79.8% vs 62.7%) 
and had lower incomes than whites (51.3% vs 19.5% had 
incomes ,US$20K). There were no racial differences in 
body mass index, likelihood of being employed, having 
health insurance, or having a diabetes-medication regimen 
that included insulin.
racial differences in psychosocial 
characteristics
African Americans and whites differed significantly on 
several diabetes-related psychosocial characteristics 
(see Table 3). Compared with whites, African Americans 
reported more interference of diabetes with daily life, greater 
severity of diabetes, and more diabetes-related emotional 
distress. In contrast, African Americans reported having 
access to more resources to support illness management 
and more diabetes-related social support. African Americans 
and whites did not differ in positive reinforcing behaviors or 
misguided support behaviors from significant others, or on 
levels of self efficacy or outcome expectancies for diabetes 
self-care behaviors.
Table 2 Demographic and clinical characteristics of white and African American adults with type 2 diabetes
Non-hispanic white (n = 203) African American (n = 79) Pa
Age (mean ± sD)  57.3 ± 11.1 51.1 ±8.9 0.001
Years of formal education 15.0 ± 3.0 13.4 ±2.4 0.0001
Body mass index 34.6 ±7.0 35.3 ±9.5 0.55
caloric expenditure/week 3354.8 ± 2612.9 4228.3 ±3175.5 0.03
comorbidity disease index 3.9 ± 2.1 3.3 ±2.0 0.02
Beck’s depression index 0.5 ± 0.4 0.6 ±0.5 0.08
Women (n %)  126 62.7% 63 79.8% 0.006
income 0.0001
  Less than $20,000 38 19.5% 40 51.3%
  $20,000–$50,000  87 44.6% 23 29.5%
  greater than $50,000 70 35.9% 15 19.2%
employment status  0.34
  employed 122 60.7% 43 54.4%
  not employed 79 39.3% 36 45.6%
Health insurance status 0.91
  insured 190 94.5% 74 94.9%
  not insured 11 5.5% 4 5.1%
Medication regimen 0.28
  includes insulin 37 19.4% 19 25.3%
  Does not include insulin 154 80.6% 56 74.7%
Notes: acomparisons between white and African American participants were made using t-tests (or non-parametric equivalent) for means and χ2 tests for frequencies.Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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race differences in HbA1c
African Americans (mean = 8.14, standard deviation = 2.53) 
had significantly higher HbA1c levels than whites (mean = 7.40, 
standard deviation = 1.71) in analyses not adjusting for 
any demographic, clinical, or psychosocial characteristics 
  (standardized beta = 0.17, P , 0.01) (Table 4, Model 1). This 
race difference persisted after adjusting for demographic and 
clinical factors that varied by race in bivariate analyses (stan-
dardized beta = 0.15, P = 0.02) (Table 4, Model 2). In a model 
that also included diabetes-related psychosocial f  actors that 
differed by race, race continued to be a significant   predictor of 
HbA1c (standardized beta = 0.18, P , 0.01) (Table 4, Model 3). 
In this model, access to illness-  management resources was 
negatively associated with HbA1c (standardized beta = −0.25, 
P , 0.01) and perceived severity of diabetes was positively 
associated with HbA1c (standardized beta = 0.21, P = 0.02). 
HbA1c was not associated with interference of diabetes with 
daily life, diabetes-related social support, or diabetes-related 
emotional distress in the final adjusted model. We ran a series 
of additional models to test whether there were significant 
Table 3 Psychosocial characteristics (mean ± sD) of white and African American patients with type 2 diabetes
Non-hispanic white African American Pa
Access to illness-management resources  2.5 ± 0.5 2.8 ± 0.6 0.0005
interference of diabetes with daily life 1.3 ± 1.3 1.7 ± 1.4 0.01
Perceived severity of diabetes 3.3 ± 1.7 3.8 ± 1.8 0.04
Perceived diabetes-related social support 3.2 ± 1.5 3.6 ± 1.4 0.047
Positive reinforcing behaviors 2.1 ± 1.6 2.5 ± 1.9 0.16
Misguided support behaviors 1.9 ± 1.7 2.4 ± 2.0 0.17
Self-efficacy in diabetes self-management 40.7 ± 20.0 38.1 ± 19.5 0.35
Outcome expectancies for self-care behaviors 61.4 ± 7.9 59.9 ± 12.1 0.31
Diabetes-related emotional distress 33.4 ± 20.8 40.1 ± 22.9 0.02
Notes: acomparisons between white and African American participants were made using t-tests (or nonparametric equivalent).
Table 4 Multiple linear regression models examining the association of race with HbA1c after adjusting for demographic, clinical, and 
diabetes-related psychosocial factors that differ by race
Variables Model 1: race Model 2: model 1 + demographic  
and clinical factors
Model 3: model 2 + diabetes-
related psychosocial factors
B SE Beta P B SE Beta P  B SE Beta P
African American 0.73 0.26 0.17 ,0.01 0.69 0.30 0.15 0.02 0.82 0.31 0.18 ,0.01
Age −0.008 0.01 −0.05 0.50 0.005 0.01 0.03 0.68
Years of formal education −0.0003 0.04 −0.0004 1.00 0.01 0.04 0.02 0.81
caloric expenditure/ 
week (Kcal)
−0.09 0.04 −0.13 0.04 −0.06 0.05 −0.08 0.22
comorbidity disease index −0.13 0.06 −0.14 0.04 −0.16 0.07 −0.17 ,0.01
Beck’s depression index 0.67 0.30 0.15 0.03 0.13 0.35 0.03 0.71
Women −0.19 0.27 −0.05 0.47 −0.22 0.28 −0.05 0.42
income 0.45 0.54
  $20,000–$50,000  0.41 0.31 0.10 0.19 0.31 0.31 0.07 0.32
  greater than $50,000 0.28 0.34 0.06 0.41 0.07 0.34 0.02 0.84
Access to illness- 
management resources
−0.95 0.30 −0.25 ,0.01
interference of diabetes  
with daily life
0.02 0.12 0.01 0.87
Perceived severity  
of diabetes
0.25 0.10 0.21 0.02
Perceived diabetes-related  
social support
0.08 0.10 0.06 0.44
Diabetes-related  
emotional distress
−0.0008 0.009 −0.008 0.93
Abbreviations: B, unstandardized regression coefficient; SE, standard error; Beta, standardized regression coefficient.Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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interactions between race and each of the demographic, clini-
cal, or diabetes-related psychosocial factors that were included 
in the multivariable analyses. No interactions were significant 
(data not shown), indicating that the associations between each 
variable and HbA1c were similar across the two racial groups.
Discussion
The current study examined whether African   American and 
white patients with type 2 diabetes differ on diabetes-related 
psychosocial factors, and whether race differences in 
  glycemic control persist after taking into account such 
  differences. We found race differences in some, but not 
all psychosocial factors examined in this study. Compared 
with whites, African Americans reported more interference 
of diabetes with daily life, greater severity of diabetes, and 
more diabetes-related emotional distress. However,   African 
Americans may have more   supportive environments to 
help them cope, as they reported more overall access to 
  support resources to help them manage their illness and 
more diabetes-related social support from their family, 
friends, and health professionals. Interestingly, African 
Americans and whites did not differ on self-management 
self-efficacy or perceived benefits of engaging in self-care 
behavior. This pattern of results suggests that coping with 
diabetes may pose more challenges for African Americans 
than for whites, but that African Americans may have more 
supportive environments than whites to help them cope, 
and that both groups have equal confidence in their ability 
to manage their disease and the utility of doing so.
That being said, we found that African Americans had 
higher HbA1c levels than whites, even after controlling for 
racial differences in the diabetes-related psychosocial 
factors noted above. This suggests that the persistent race 
disparity in glycemic control is independent of diabetes-
related psychosocial factors such as support received from 
significant others or the broader community, self efficacy in 
diabetes management, beliefs about the utility of engaging 
in recommended self-care behaviors,   interference of the dis-
ease with daily life, or distress caused by the   disease. Even 
though race differences were found in some of these areas, 
the race difference in glycemic control was still observed 
after taking those psychosocial factors into account.
Explanations for the race difference in glycemic control 
therefore remain elusive. Recent work has emphasized the 
role of socioeconomic status (SES) on diabetes prevalence, 
as SES is often confounded with race.60–62 For instance, 
in a sample of white, African American, and Hispanic 
adults, race differences in diabetes prevalence were greatly 
reduced after controlling for a combination of education 
and income.61 Moreover, no racial differences in diabetes 
prevalence were found in a sample of African American 
and white adults drawn from a racially integrated urban 
community where members of both races lived in similar 
social conditions and did not differ in socioeconomic 
  status.62 The current study, which focused on glycemic 
control rather than diabetes prevalence, found that race dif-
ferences in glycemic control persisted even after controlling 
for education and income, demographic   characteristics that 
serve as indicators of SES. It is possible, however, that our 
measures of SES did not capture other important racial dif-
ferences in life circumstances that affect glycemic control. 
For instance, African American and white patients in the 
current study were likely drawn from poorly integrated 
communities, as rates of racial segregation remain high in 
many Pittsburgh neighborhoods. Residential segregation 
has been proposed as a contributing factor to racial dispari-
ties in health, given that it leads to differences in access 
to high-quality health care, exposure to   environmental 
hazards, access to healthy and unhealthy foods, and rec-
reational facilities that promote physical activity, all of 
which can influence health.63   Additional research is needed 
to determine whether environmental factors not examined 
in the current analysis contribute to race disparities in 
glycemic control.
Even though this study found that the race   disparity 
in glycemic control was independent of   diabetes-related 
  psychosocial factors, its results can inform the   development 
of interventions to improve diabetes management for both 
African American and white patients. Our findings suggest 
that interventions may not need to be designed to target 
different psychosocial factors for African Americans 
and whites. Our results indicate that access to illness-
  management resources is related to glycemic control 
for both African Americans and whites. Interventions 
designed to increase access to support from a variety of 
sources ranging from close friends and family to more 
distal sources such as the workplace, community, and 
the media may be a   promising way to improve   glycemic 
control for all patients. Such resources may already 
be more available to African   Americans than whites, 
as African Americans reported more access to illness-
  management resources than whites in the current study, 
and a similar trend has been reported in a previous study 
with a much smaller sample.64 The relatively greater Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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access to resources reported by African Americans in 
the current study may reflect the effects of multiple 
  community-based programs designed to provide African 
American   communities in Pittsburgh with support related 
to chronic disease management, disease prevention, and 
promotion of healthy lifestyles. The task of optimizing the 
impact of such resources on glycemic control remains an 
important area for future efforts.
The current study has several limitations. First, the 
sample consisted of patients who self-selected into a study 
of a behavioral intervention designed to improve diabetes 
self-management. Therefore, the study sample may not be 
representative of the general population of patients with 
diabetes in terms of disease severity or motivation to engage 
in diabetes self-care behaviors. Second, while the study 
recruited the expected number of African Americans given 
the race distribution in the region, the number of African 
Americans in the sample is small, limiting the generalizability 
of the findings. Finally, the cross-sectional nature of the study 
prevents conclusions about causal relationships between the 
variables examined. For example, it is possible that having 
poorly controlled diabetes may lead patients to perceive their 
disease as more severe rather than poor glycemic control 
being caused by perceptions that one’s disease is severe.
Despite these limitations, the current study adds to exist-
ing literature by identifying differences and similarities in 
diabetes-related psychosocial factors across African American 
and white patients with diabetes, and by showing that the race 
disparity in glycemic control is independent of differences in 
such factors. Access to illness-management resources is associ-
ated with better glycemic control for both African Americans 
and whites, which suggests one potential area for the develop-
ment of interventions to improve diabetes management.
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